TRX — Tissue Regenix Share News
0.000.00%
HealthcareSpeculativeMicro Cap
- £5.18m
- £12.00m
- $28.65m
Confirmation of results
Grant of share options
Brief: Tissue Regenix H1 Revenue USD 16.4 Mln
Brief: Tissue Regenix Says HY Trading In Line With Its Expectations
Half-Year Trading Update
Holding(s) in Company
Holding(s) in Company
Exercise of Options, Director Dealing and TVR
Holding(s) in Company
Final results for the year ended 31 December 2023
Notice of Results
Brief: Tissue Regenix Announces First EU Shipment & New Distributor Agreements
First EU shipment & new distributor agreements
Holding(s) in Company
Brief: Tissue Regenix Group Sees FY Adjusted EBITDA Ahead Of Expectations
Trading update for 2023
2023 LTIP Grant
Holding(s) in Company
Director/PDMR Shareholding